We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$501M
AUM Growth
-$63.3M
Cap. Flow
-$45.4M
Cap. Flow %
-9.05%
Top 10 Hldgs %
56.05%
Holding
39
New
2
Increased
14
Reduced
13
Closed
10

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$27.2M
2
XRAY icon
Dentsply Sirona
XRAY
+$15.5M
3
QGEN icon
Qiagen
QGEN
+$8.93M
4
CAH icon
Cardinal Health
CAH
+$8.39M
5
BSX icon
Boston Scientific
BSX
+$7.36M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$21.6M
2
GILD icon
Gilead Sciences
GILD
+$14.5M
3
HSIC icon
Henry Schein
HSIC
+$12.3M
4
RVTY icon
Revvity
RVTY
+$10.4M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$9.84M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
Merck
MRK
$315B
$61M 12.18%
812,814
+357,367
+78% +$27.2M
PFE icon
2
Pfizer
PFE
$143B
$28M 5.59%
651,600
-488,385
-43% -$21.6M
BMY icon
3
Bristol-Myers Squibb
BMY
$124B
$26.3M 5.25%
445,010
-78,483
-15% -$5.17M
BSX icon
4
Boston Scientific
BSX
$65.4B
$26.1M 5.22%
602,682
+166,276
+38% +$7.36M
GILD icon
5
Gilead Sciences
GILD
$167B
$25.9M 5.17%
371,085
-206,283
-36% -$14.5M
CAH icon
6
Cardinal Health
CAH
$53.5B
$25.9M 5.17%
523,606
+154,675
+42% +$8.39M
BIIB icon
7
Biogen
BIIB
$30.4B
$23.6M 4.7%
83,319
+10,276
+14% +$3.37M
MDT icon
8
Medtronic
MDT
$106B
$23.2M 4.62%
184,700
-24,428
-12% -$3.16M
INCY icon
9
Incyte
INCY
$23.4B
$20.8M 4.15%
302,739
+18,594
+7% +$1.41M
BDX icon
10
Becton Dickinson
BDX
$43.6B
$20.1M 4%
83,633
-13,415
-14% -$3.29M
BAX icon
11
Baxter International
BAX
$11.7B
$19.1M 3.81%
237,429
+44,690
+23% +$3.53M
BRKR icon
12
Bruker
BRKR
$8.86B
$18.2M 3.63%
233,252
-73,398
-24% -$6.1M
OGN icon
13
Organon & Co
OGN
$3.55B
$17.9M 3.57%
546,062
-6,170
-1% -$197K
NUVA
14
DELISTED
NuVasive, Inc.
NUVA
$17.9M 3.56%
298,426
+4,672
+2% +$288K
QGEN icon
15
Qiagen
QGEN
$8.49B
$17.1M 3.4%
311,416
+160,470
+106% +$8.93M
ELV icon
16
Elevance Health
ELV
$80.9B
$16.1M 3.21%
43,192
-1,432
-3% -$544K
CVS icon
17
CVS Health
CVS
$137B
$14.9M 2.98%
176,120
-24,321
-12% -$2.04M
XRAY icon
18
Dentsply Sirona
XRAY
$2.81B
$14.6M 2.91%
+251,330
New +$15.5M
CNC icon
19
Centene
CNC
$32.8B
$13.2M 2.64%
212,223
-17,187
-7% -$1.15M
ELAN icon
20
Elanco Animal Health
ELAN
$12.9B
$13.1M 2.61%
409,731
+13,253
+3% +$445K
LH icon
21
Labcorp
LH
$23.2B
$10.7M 2.13%
44,067
-6,622
-13% -$1.67M
IONS icon
22
Ionis Pharmaceuticals
IONS
$8.99B
$8.85M 1.77%
263,870
+382
+0.1% +$14.4K
BIO icon
23
Bio-Rad Laboratories Class A
BIO
$8.15B
$8.4M 1.67%
11,255
-4,881
-30% -$3.66M
UHS icon
24
Universal Health Services
UHS
$9.15B
$6.96M 1.39%
50,295
+21,084
+72% +$3.19M
RIGL icon
25
Rigel Pharmaceuticals
RIGL
$750M
$6.43M 1.28%
177,273
+6,718
+4% +$264K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2021 Portfolio in Review

As of Q3 2021, Sector Gamma AS held 39 positions worth $501M, down 11% from $565M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sector Gamma AS withdrew a net $45.4M in Q3 2021, closing 10 positions and reducing 13 holdings. Its most notable exit was Henry Schein, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Dentsply Sirona worth $14.6M.

  • Sector Gamma AS's largest Q3 2021 buy was Dentsply Sirona: 251,330 shares worth $14.6M.
  • Sector Gamma AS added most to Merck in Q3 2021, an estimated $27.2M increase.
  • Sector Gamma AS's biggest Q3 2021 reduction was Pfizer, cutting an estimated $21.6M.
  • Sector Gamma AS fully exited Henry Schein in Q3 2021, selling an estimated $12.3M.
  • Sector Gamma AS's ten largest holdings make up 56% of its $501M portfolio in Q3 2021.
  • Sector Gamma AS opened 2 new positions and closed 10 in Q3 2021.
  • Sector Gamma AS's portfolio value fell 11% quarter-over-quarter to $501M.

Based on Sector Gamma AS's 13F filing for Q3 2021, filed 29 Oct 2021.